These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16767560)

  • 1. Drug eruption due to bosentan in a patient with systemic sclerosis.
    Nagai Y; Yamanaka M; Nishimura S; Nakano A; Hasegawa A; Ishikawa O
    Mod Rheumatol; 2006; 16(3):188-90. PubMed ID: 16767560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin receptor antagonist bosentan improves the dermal sclerosis in a patient with systemic sclerosis.
    Nishibu A; Sakai E; Oyama N; Yamamoto T
    Australas J Dermatol; 2012 May; 53(2):e32-3. PubMed ID: 22571581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe hepatotoxicity in a patient on bosentan upon addition of methotrexate: reversible with resumption of methotrexate without bosentan.
    Dwyer N; Jones G; Kilpatrick D
    J Clin Rheumatol; 2009 Mar; 15(2):88-9. PubMed ID: 19265355
    [No Abstract]   [Full Text] [Related]  

  • 4. Ironic case of hepatic dysfunction following the global withdrawal of sitaxentan.
    Don GW; Joseph F; Celermajer DS; Corte TJ
    Intern Med J; 2012 Dec; 42(12):1351-4. PubMed ID: 23253000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bosentan: a considerable increase in the survival of patients with pulmonary hypertension associated with systemic rheumatic diseases].
    Volkov AV; Iudkina NN; Nikolaeva EV; Kurmukov IA; Glukhova SI; Nasonov EL
    Ter Arkh; 2014; 86(5):32-9. PubMed ID: 25026800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin-I receptor antagonist for the treatment of pulmonary arterial hypertension in systemic sclerosis.
    Varga J
    Curr Rheumatol Rep; 2003 Apr; 5(2):145-6. PubMed ID: 12628045
    [No Abstract]   [Full Text] [Related]  

  • 7. Bosentan in systemic sclerosis.
    Heresi GA; Minai OA
    Drugs Today (Barc); 2008 Jun; 44(6):415-28. PubMed ID: 18596996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver impairment after concomitant administration of bosentan and clarithromycin in systemic sclerosis.
    Caramaschi P; Mahamid H; Bambara LM; Biasi D
    Joint Bone Spine; 2010 Jan; 77(1):81-2. PubMed ID: 20022782
    [No Abstract]   [Full Text] [Related]  

  • 9. Resolution of severe digital ulceration during a course of Bosentan therapy.
    Snyder MJ; Jacobs MR; Grau RG; Wilkes DS; Knox KS
    Ann Intern Med; 2005 May; 142(9):802-3. PubMed ID: 15867420
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.
    Channick RN; Simonneau G; Sitbon O; Robbins IM; Frost A; Tapson VF; Badesch DB; Roux S; Rainisio M; Bodin F; Rubin LJ
    Lancet; 2001 Oct; 358(9288):1119-23. PubMed ID: 11597664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary arterial hypertension therapy may be safe and effective in patients with systemic sclerosis and borderline pulmonary artery pressure.
    Kovacs G; Maier R; Aberer E; Brodmann M; Graninger W; Kqiku X; Scheidl S; Tröster N; Hesse C; Rubin L; Olschewski H
    Arthritis Rheum; 2012 Apr; 64(4):1257-62. PubMed ID: 22127844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.
    Denton CP; Humbert M; Rubin L; Black CM
    Ann Rheum Dis; 2006 Oct; 65(10):1336-40. PubMed ID: 16793845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed hypersensitivity to bosentan.
    Romano A; Giovannetti A; Caruso C; Rosato E; Pierdominici M; Salsano F
    Allergy; 2009 Mar; 64(3):499-501. PubMed ID: 19220223
    [No Abstract]   [Full Text] [Related]  

  • 14. Bosentan therapy for pulmonary arterial hypertension.
    Rubin LJ; Badesch DB; Barst RJ; Galie N; Black CM; Keogh A; Pulido T; Frost A; Roux S; Leconte I; Landzberg M; Simonneau G
    N Engl J Med; 2002 Mar; 346(12):896-903. PubMed ID: 11907289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil.
    Launay D; Sitbon O; Le Pavec J; Savale L; Tchérakian C; Yaïci A; Achouh L; Parent F; Jais X; Simonneau G; Humbert M
    Rheumatology (Oxford); 2010 Mar; 49(3):490-500. PubMed ID: 20015974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of pulmonary arterial hypertension (PAH) with oral endothelin-receptor antagonist bosentan in systemic sclerosis: BREATHE-1 trial and clinical experience].
    Ahmadi-Simab K; Lamprecht P; Hellmisch B; Gross WL
    Z Rheumatol; 2004 Dec; 63(6):495-7. PubMed ID: 15605216
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of systemic sclerosis digital ulcers and pulmonary arterial hypertension with endothelin receptor antagonist bosentan.
    Humbert M; Cabane J
    Rheumatology (Oxford); 2003 Jan; 42(1):191-3. PubMed ID: 12509640
    [No Abstract]   [Full Text] [Related]  

  • 18. Secondary pulmonary arterial hypertension: treated with endothelin receptor blockade.
    Sharma S; Kashour T; Philipp R
    Tex Heart Inst J; 2005; 32(3):405-10. PubMed ID: 16392231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bosentan for severe pulmonary arterial hypertension related to systemic sclerosis with interstitial lung disease.
    Ahmadi-Simab K; Hellmich B; Gross WL
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():44-8. PubMed ID: 16919010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bosentan may induce arthritis flare in patients with scleroderma concomitantly treated with methotrexate.
    Cozzi F; Ostuni PA; Marotta H; Sfriso P; Favaro M; Todesco S
    Ann Rheum Dis; 2006 May; 65(5):692-3. PubMed ID: 16611872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.